Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2008; 14(47): 7208-7213
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7208
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7208
Vitamin E | Placebo | |
Total | 56 | 20 |
Sex (%) | ||
Female | 22 (39.3) | 8 (40) |
Male | 34 (60.7) | 12 (60) |
Age (yr) | 10.4 | 11.8 |
Alanine transaminase level (%) | ||
Normal | 33 (58.9) | 13 (65) |
Elevated | 23 (41.1) | 7 (35) |
More than double above normal level | 8 | 2 |
HBV-DNA (%) | ||
< 1000 pg/mL | 22 (39.3) | 7 (35) |
> 1000 pg/mL | 35 (60.7) | 13 (65) |
Route of transmission (%) | ||
Parenteral | 1 (1.8) | 1 (5) |
Vertical | 34 (60.7) | 10 (50) |
Unknown | 21 (37.5) | 9 (45) |
Interferon alpha pre-treatment (%)1 | 11 (19.6) | 4 (20) |
Lamivudine pre-treatment (%)1 | 5 (8.9) | 3 (15) |
HBeAg seroconversion (%)2 | 16 (28.6) | 2 (10) |
- Citation: Gerner P, Posselt HG, Krahl A, Ballauff A, Innerhofer A, Binder C, Wenzl TG, Zense M, Hector A, Dockter G, Adam R, Neubert J, Claßen M, Gemmern RV, Wirth S. Vitamin E treatment for children with chronic hepatitis B: A randomized placebo controlled trial. World J Gastroenterol 2008; 14(47): 7208-7213
- URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7208.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.7208